IBDEI0JB ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9454,1,4,0)
 ;;=4^458.0
 ;;^UTILITY(U,$J,358.3,9454,1,5,0)
 ;;=5^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,9454,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,9455,0)
 ;;=420.91^^67^662^72
 ;;^UTILITY(U,$J,358.3,9455,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9455,1,4,0)
 ;;=4^420.91
 ;;^UTILITY(U,$J,358.3,9455,1,5,0)
 ;;=5^Pericarditis, Acute idiopathic
 ;;^UTILITY(U,$J,358.3,9455,2)
 ;;=   ^269695
 ;;^UTILITY(U,$J,358.3,9456,0)
 ;;=780.2^^67^662^80
 ;;^UTILITY(U,$J,358.3,9456,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9456,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,9456,1,5,0)
 ;;=5^Syncope
 ;;^UTILITY(U,$J,358.3,9456,2)
 ;;=Syncope^116707
 ;;^UTILITY(U,$J,358.3,9457,0)
 ;;=443.9^^67^662^65
 ;;^UTILITY(U,$J,358.3,9457,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9457,1,4,0)
 ;;=4^443.9
 ;;^UTILITY(U,$J,358.3,9457,1,5,0)
 ;;=5^PVD
 ;;^UTILITY(U,$J,358.3,9457,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,9458,0)
 ;;=440.21^^67^662^67
 ;;^UTILITY(U,$J,358.3,9458,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9458,1,4,0)
 ;;=4^440.21
 ;;^UTILITY(U,$J,358.3,9458,1,5,0)
 ;;=5^PVD w/ intermittent claudication
 ;;^UTILITY(U,$J,358.3,9458,2)
 ;;=^293885
 ;;^UTILITY(U,$J,358.3,9459,0)
 ;;=440.23^^67^662^68
 ;;^UTILITY(U,$J,358.3,9459,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9459,1,4,0)
 ;;=4^440.23
 ;;^UTILITY(U,$J,358.3,9459,1,5,0)
 ;;=5^PVD w/ ulceration
 ;;^UTILITY(U,$J,358.3,9459,2)
 ;;=^295739
 ;;^UTILITY(U,$J,358.3,9460,0)
 ;;=440.24^^67^662^66
 ;;^UTILITY(U,$J,358.3,9460,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9460,1,4,0)
 ;;=4^440.24
 ;;^UTILITY(U,$J,358.3,9460,1,5,0)
 ;;=5^PVD w/ Gangrene
 ;;^UTILITY(U,$J,358.3,9460,2)
 ;;=PVD w/ Gangrene^295740
 ;;^UTILITY(U,$J,358.3,9461,0)
 ;;=V45.81^^67^662^76
 ;;^UTILITY(U,$J,358.3,9461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9461,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,9461,1,5,0)
 ;;=5^S/P CABG
 ;;^UTILITY(U,$J,358.3,9461,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,9462,0)
 ;;=459.81^^67^662^86
 ;;^UTILITY(U,$J,358.3,9462,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9462,1,4,0)
 ;;=4^459.81
 ;;^UTILITY(U,$J,358.3,9462,1,5,0)
 ;;=5^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,9462,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,9463,0)
 ;;=V45.01^^67^662^78
 ;;^UTILITY(U,$J,358.3,9463,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9463,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,9463,1,5,0)
 ;;=5^S/P Pacer Placement
 ;;^UTILITY(U,$J,358.3,9463,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,9464,0)
 ;;=427.31^^67^662^13
 ;;^UTILITY(U,$J,358.3,9464,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9464,1,4,0)
 ;;=4^427.31
 ;;^UTILITY(U,$J,358.3,9464,1,5,0)
 ;;=5^Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,9464,2)
 ;;=^11378
 ;;^UTILITY(U,$J,358.3,9465,0)
 ;;=427.89^^67^662^15
 ;;^UTILITY(U,$J,358.3,9465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9465,1,4,0)
 ;;=4^427.89
 ;;^UTILITY(U,$J,358.3,9465,1,5,0)
 ;;=5^Bradycardia
 ;;^UTILITY(U,$J,358.3,9465,2)
 ;;=Bradycardia^87896
 ;;^UTILITY(U,$J,358.3,9466,0)
 ;;=427.9^^67^662^21
 ;;^UTILITY(U,$J,358.3,9466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9466,1,4,0)
 ;;=4^427.9
 ;;^UTILITY(U,$J,358.3,9466,1,5,0)
 ;;=5^Cardiac Dysrythmia
 ;;^UTILITY(U,$J,358.3,9466,2)
 ;;=^10166
 ;;^UTILITY(U,$J,358.3,9467,0)
 ;;=427.0^^67^662^70
 ;;^UTILITY(U,$J,358.3,9467,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9467,1,4,0)
 ;;=4^427.0
 ;;^UTILITY(U,$J,358.3,9467,1,5,0)
 ;;=5^Paroxysmal Supravent Tachycardia
 ;;^UTILITY(U,$J,358.3,9467,2)
 ;;=^90479
 ;;^UTILITY(U,$J,358.3,9468,0)
 ;;=427.81^^67^662^79
